Albert David Limited (NSE:ALBERTDAVD)
812.60
+3.25 (0.40%)
May 29, 2025, 9:29 AM IST
Albert David Revenue
In the fiscal year ending March 31, 2025, Albert David had annual revenue of 3.46B INR, down -4.61%. Albert David had revenue of 748.93M in the quarter ending March 31, 2025, a decrease of -15.90%.
Revenue
3.46B
Revenue Growth
-4.61%
P/S Ratio
1.34
Revenue / Employee
2.31M
Employees
1,497
Market Cap
4.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 3.46B | -166.94M | -4.61% |
Mar 31, 2024 | 3.62B | 208.97M | 6.12% |
Mar 31, 2023 | 3.42B | 280.53M | 8.95% |
Mar 31, 2022 | 3.14B | 660.62M | 26.70% |
Mar 31, 2021 | 2.47B | -733.45M | -22.86% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 211.46B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 127.57B |